[ Price : $8.95]
An FDA inspection cites multiple quality control and aseptic processing concerns at Staska Pharmaceuticals.[ Price : $8.95]
FDA posts updated guidance outlining how drugmakers should design clinical development programs for new tuberculosis treatments, e...[ Price : $8.95]
FDA delays by three months its decision on Eisai and Biogen's subcutaneous starting-dose formulation of Alzheimers drug Leqembi (l...[ Price : $8.95]
A legal analysis published by Crowell & Moring says a proposed FDA pilot program on artificial intelligence in early-stage clinica...[ Price : $8.95]
President Trump tells reporters he knows nothing about reports suggesting FDA commissioner Marty Makary will be asked to resign so...[ Price : $8.95]
FDA seeks public input on ways to expand drug repurposing efforts, aiming to accelerate treatment options for patients with unmet ...[ Price : $8.95]
FDA issues updated guidance for companies developing therapies to treat, prevent or reduce recurrence of Clostridioides difficile ...[ Price : $8.95]
FDA releases a new guidance outlining how drugmakers should design and conduct postapproval studies evaluating the safety of drugs...